Tradewinds Capital Management, LLC Moderna, Inc. Transaction History

Tradewinds Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	SELL	$118.07 - $194.18 $2,951 - $4,854	-25 Reduced 75.76%	8 $1,000
Q2 2022 Jul 21, 2022	SELL	$117.13 - $176.59 $14,524 - $21,897	-124 Reduced 78.98%	33 $5,000
Q1 2022 Apr 25, 2022	BUY	$126.46 - $235.05 $505 - $940	4 Added 2.61%	157 $27,000
Q4 2021 Feb 02, 2022	SELL	$225.82 - $368.51 $5,193 - $8,475	-23 Reduced 13.07%	153 $39,000
Q3 2021 Nov 04, 2021	SELL	$221.9 - $484.47 $12,648 - $27,614	-57 Reduced 24.46%	176 $68,000
Q2 2021 Jul 30, 2021	SELL	$129.91 - $234.98 $53,912 - $97,516	-415 Reduced 64.04%	233 $55,000
Q4 2020 Feb 10, 2021	BUY	$65.74 - $169.86 $34,579 - $89,346	526 Added 431.15%	648 $68,000
Q3 2020 Oct 26, 2020	SELL	$54.34 - $94.85 $4,238 - $7,398	-78 Reduced 39.0%	122 $9,000
Q2 2020 Aug 11, 2020	BUY	$29.67 - $80.0 $5,934 - $16,000	200 New	200 $13,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Tradewinds Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tradewinds Capital Management, LLC with notifications on news.